Saving Hearts, Kidneys and Lives in Type 2 Diabetes - Results from the FLOW Trial

In this episode of Diabetes Insights, we dive into the latest findings from the FLOW Trial - a groundbreaking trial evaluating the impact of GLP-1 receptor agonists on chronic kidney disease (CKD). This discussion features expert insights from Dr. Peter Rossing, Dr. Richard Pratley and Dr. Katherine Tuttle. The results reveal a 24% reduction in kidney disease progression, an 18% decrease in major cardiovascular events, and a 20% drop in total mortality - findings that could reshape clinical practice. Tune in to explore how this research is transforming diabetes and kidney disease management.

Om Podcasten

EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at the EASD Annual Meeting 2024 in Madrid, Spain. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/home.html). New episode released every Friday.